Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes

BACKGROUND: Platelet inhibition is crucial in reducing both short- and long-term atherothrombotic risks in patients with acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI). Based on randomised trials, recent recommendations in the current guidelines include the endo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yetgin, T., van der Linden, M. M. J. M., de Vries, A. G., Smits, P. C., Boersma, E., van Geuns, R.-J. M., Zijlstra, F.
Format: Artigo
Idioma:Inglês
Publicat: Bohn Stafleu van Loghum 2013
Matèries:
Design Study Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3967557/
https://ncbi.nlm.nih.gov/pubmed/24072688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12471-013-0472-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars